Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Insulin resistance and acne: a new risk factor for men?

Del Prete M, Mauriello MC, Faggiano A, Di Somma C, Monfrecola G, Fabbrocini G, Colao A.

Endocrine. 2012 Dec;42(3):555-60. doi: 10.1007/s12020-012-9647-6. Epub 2012 Mar 25.

PMID:
22447309
2.

Relation between androgens and cardiovascular risk factors in a young population.

Gannagé-Yared MH, Chedid R, Abs L.

Clin Endocrinol (Oxf). 2011 Jun;74(6):720-5. doi: 10.1111/j.1365-2265.2011.03987.x.

PMID:
21521259
3.

Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.

Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.

Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.

PMID:
18063948
4.

Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne.

Aizawa H, Niimura M.

J Dermatol. 1996 Aug;23(8):526-9.

PMID:
8854583
5.

Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.

PMID:
15977101
6.
7.

[Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].

Liang L, Zou CC, Li Y, Wang CL, Jiang YJ, Dong GP, Fu JF, Wang XM.

Zhonghua Er Ke Za Zhi. 2006 Sep;44(9):657-61. Chinese.

PMID:
17217656
8.

Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.

Alemzadeh R, Kichler J, Calhoun M.

Eur J Endocrinol. 2010 Jun;162(6):1093-9. doi: 10.1530/EJE-10-0205. Epub 2010 Apr 6.

9.

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.

Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM.

Clin Endocrinol (Oxf). 1999 Apr;50(4):517-27.

PMID:
10468913
10.

Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.

Fulghesu A, Magnini R, Portoghese E, Angioni S, Minerba L, Melis GB.

J Adolesc Health. 2010 May;46(5):474-81. doi: 10.1016/j.jadohealth.2009.10.008. Epub 2010 Jan 4.

PMID:
20413084
11.

[Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].

Roa Barrios M, Arata-Bellabarba G, Valeri L, Velázquez-Maldonado E.

Endocrinol Nutr. 2009 Feb;56(2):59-65. doi: 10.1016/S1575-0922(09)70553-4. Epub 2009 May 1. Spanish.

PMID:
19627713
13.
14.

Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.

Ulgen F, Herder C, Kühn MC, Willenberg HS, Schott M, Scherbaum WA, Schinner S.

Arch Physiol Biochem. 2010 May;116(2):57-62. doi: 10.3109/13813451003631421.

PMID:
20222849
15.

Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.

Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.

Fertil Steril. 1991 May;55(5):895-9.

PMID:
1708731
16.

Body fat distribution and their associations with cardiovascular risk, insulin resistance and β-cell function: are there differences between men and women?

Chen G, Liu C, Chen F, Yao J, Jiang Q, Chen N, Huang H, Liang J, Li L, Lin L.

Int J Clin Pract. 2011 May;65(5):592-601. doi: 10.1111/j.1742-1241.2011.02653.x.

PMID:
21489083
17.
18.

Obesity indices and major components of metabolic syndrome in young adult Arab subjects.

Al-Shayji IA, Akanji AO.

Ann Nutr Metab. 2004;48(1):1-7. Epub 2003 Nov 20.

PMID:
14639040
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk